key: cord-0726297-r6yl7xd0
authors: Yan, Renhong; Wang, Ruoke; Ju, Bin; Yu, Jinfang; Zhang, Yuanyuan; Liu, Nan; Wang, Jia; Zhang, Qi; Chen, Peng; Zhou, Bing; Li, Yaning; Zhang, Shuyuan; Tian, Long; Zhong, Xinyue; Cheng, Lin; Ge, Xiangyang; Zhao, Juanjuan; Wang, Hong-Wei; Wang, Xinquan; Zhang, Zheng; Zhang, Linqi; Zhou, Qiang
title: Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
date: 2020-10-13
journal: bioRxiv
DOI: 10.1101/2020.10.13.336800
sha: 854f864f7338681a63f84d05fb6278a37b22e90b
doc_id: 726297
cord_uid: r6yl7xd0

Neutralizing monoclonal antibodies (nAbs) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represent promising candidates for clinical intervention against coronavirus virus diseases 2019 (COVID-19). We isolated a large number of nAbs from SARS-CoV-2 infected individuals capable of disrupting proper interaction between the receptor binding domain (RBD) of the viral spike (S) protein and the receptor angiotensin converting enzyme 2 (ACE2). In order to understand the mechanism of these nAbs on neutralizing SARS-CoV-2 virus infections, we have performed cryo-EM analysis and here report cryo-EM structures of the ten most potent nAbs in their native full-length IgG or Fab forms bound to the trimeric S protein of SARS-CoV-2. The bivalent binding of the full-length IgG is found to associate with more RBD in the “up” conformation than the monovalent binding of Fab, perhaps contributing to the enhanced neutralizing activity of IgG and triggering more shedding of the S1 subunit from the S protein. Comparison of large number of nAbs identified common and unique structural features associated with their potent neutralizing activities. This work provides structural basis for further understanding the mechanism of nAbs, especially through revealing the bivalent binding and their correlation with more potent neutralization and the shedding of S1 subunit.

The global pandemic of coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious threat to human health(1, 2). SARS-CoV-2 is an enveloped, positive-strand RNA virus, belonging to the beta-coronavirus genus that also includes SARS-CoV (3) and the Middle Eastern respiratory syndrome coronavirus (MERS-CoV) (4) that caused epidemic in 2003 and 2012, respectively. SARS-CoV-2 shares about 80% sequence identity with SARS-CoV, both use angiotensin-converting enzyme 2 (ACE2) as their cellular receptor (5-9) that is recognized and bound by the trimeric spike (S) protein (10, 11) that distributes on the surface of the virion particles (12) (13) (14) and is proteolytically cleaved into N-terminal S1 subunit and C-terminal S2 subunit during viral entry into target cells (15) . S1 contains the N-terminal domain (NTD), the receptor binding domain (RBD), the subdomain 1 and 2 and is responsible for binding to receptor. S2 mediates the fusion of the viral and cellular membrane by undergoing a dramatic conformation change from the prefusion to the postfusion state (16) accompanying with the shedding of S1. RBD, which directly binds to ACE2 receptor, is a major target for development of the therapeutic neutralizing monoclonal antibodies (nAbs) against COVID-19. The prefusion structure of S protein exhibits more dynamic conformational changes in S1 region, especially in RBD, which has two distinctive conformations: "up" and ''down'' (10, 11) . Only the "up" conformation of RBD can bind to the ACE2 receptor. Up to now, numerous nAbs against the S protein of SARS-CoV-2 have been reported (17) (18) (19) (20) (21) (22) (23) . The complex structures of these nAbs with S protein were solved, most of which utilized the Fab form of nAbs. It remains largely unknown how nAbs in their native bivalent form bind to and ever induce the conformation changes of the trimeric S protein.

To further explore the interactions between nAbs and S proteins, we solved ten cryo electron microscopy (cryo-EM) structures of the S protein in complex with nAbs, in full-length form and/or in Fab form. Bivalent binding was revealed for the full-length form nAbs, which showed that the full-length form exhibits different binding mode and induces more RBDs to the "up" conformation than the Fab form that is monovalent. It is also shown that the bivalent binding is superior in antiviral efficacy, and correlated with the improved shedding of S1 subunit. Structural comparison of large number of the complexes of nAbs with S protein identified common and unique features associated with the potent neutralizing activities of these nAbs. Our results provide an important structural basis for further understanding the working mechanism of nAbs and are helpful for antiviral drug design and vaccine development.

To understand the molecular features of the interactions of neutralizing nAbs with S protein, we characterized ten nAbs derived from various COVID-19 convalescents about the binding and neutralizing activities, and the capacity of competing with ACE2 for RBD binding. The binding affinity to RBD of SARS-CoV-2 of these nAbs measured by surface plasmon resonance varied from 0.75 to 90.09 nM ( Fig. S1A and Table 1), whereas the half maximal inhibitory concentration (IC 50 ) of these nAbs ranged from 0.0014 to 0.9231 μg/ml in the pseudo virus based assay or from 0.0043 to 0.8932 µg/ml in live SARS-CoV-2 virus based assay, respectively (Ref, Table 1 and Fig. S1 ). All of these nAbs exhibited strong competition with ACE2 to bind RBD, indicating their neutralization mechanism (Table 1 and Fig. S1 ). The variable regions of the heavy chain of these nAbs belong to diverse gene families, paired with different families of light chains. The CDR3 length of the heavy chains and the light chains ranged from 9 to 22 amino acids and from 9 to 11 amino acids, respectively (Table S1 ). The somatic hypermutation (SHM) of these nAbs were generally low and five of them reached 0% for heavy chain or light chain.

Inducing shedding of the surface proteins of viruses is an important feature for nAbs. So, we decided to examine whether the nAbs in this work can induce the shedding of the S1 subunit of the S protein of SARS-CoV-2 or not by transfecting plasmids encoding SARS-CoV-2 S protein into HEK293T cells. The results showed that some nAbs, such as P5A-2G9, could notably induce shedding of the S protein, whereas some nAbs, such as P5A-1B9 and P5A-3C12, had only a weak shedding ability and P2B-1A1 exhibited almost no shedding ability, suggesting the diversity of these nAbs in terms of inducing the shedding of S1 subunit.

To get deeper understanding of the working mechanism, we determined the complex structures of the full-length IgG form of these nAbs with the S protein of SARS-CoV-2 using single particle cryo-EM at overall resolution from 2.8 angstroms to 3.6 angstroms ( Fig. 1, Fig. S2-6 and Table S2 ). The nAbs were incubated with the S protein at excessive molar ratio and the unbound nAbs were removed by gel filtration (Fig. S2) . The structures of these S-IgG complexes can be classified into three different binding patterns ( Fig. 1) . In pattern 1 that includes P2B-1A10, P2B-1A1, P5A-2G7 and P5A-2G9, two "up" RBDs are bound with nAb. In pattern 2 that contains P5A-2F11, P5A-1B8 and P5A-1B6, two or three RBDs are in "up" conformation and bound with nAb.

P5A-1B9, the most potent nAb in this work, itself constitutes the pattern 3 that contains one "up" RBD and two "down" RBD. All of three RBDs in P5A-1B9 are bound with nAb and share the same binding interface (Fig. S9 ).

It's reported that the bivalent binding of antibodies can neutralize the virus more efficiently than Fabs in some viruses such as rhinovirus and Dengue virus (24, 25) . To examine the structural difference of the complexes of the S protein with IgG and with Fab, we further solved the complex structures of the S protein with Fab region of P5A-1B8 or P5A-2G7 (Fig. 2, Fig. S8 ). In the S/P5A-1B8(IgG) complex, two or three RBDs are in "up" conformation and bound with nAb ( Fig. 1 We also re-centered the particles of the S/P5A-1B8(IgG) complex and the S/P5A-1B8(Fab) complex at the Fab region and calculated the two-dimensional (2D) classification. The 2D class averages showed extra density near nAb of the S/P5A-1B8(IgG) complex, which might correspond to the Fc region of the P5A-1B8 (Fig. 2C) and was absent in the 2D class averages of the S/P5A-1B8(Fab) complex (Fig. 2D) .

Additionally, the Fab regions of an intact antibody molecule can be docked into the cryo-EM map of the S/P5A-1B8(IgG) complex (Fig. 2E) . Taken together, these results support the bivalent binding exists for both P5A-1B8 and P5A-2G7.

To investigate the working mechanism more deeply, we compared the neutralizing potency and the ability to induce the shedding of S1 between the IgG form and the Fab form of the nAbs. As shown in Fig. 3A , the IgG form nAbs exhibited higher neutralizing potency than the Fab-form of the same nAbs. The neutralizing IC 50 values of the IgG-form were decreased for 700-fold compared to the Fab form for P5A-1B8 and P5A-1B9, whereas P5A-2G7 exhibited even greater decreasing of more than 3,000 folds. To investigate the ability of inducing the shedding of S1 subunit for these nAbs in IgG-or Fab-forms, we incubated S protein-surface-expressed cells with IgG or Fab at saturated concentration and measured their binding over time by flow cytometry. As shown in Fig. 3B , the IgG of P5A-1B8 triggered S1 shedding most potently, which induced the shedding of S1 subunit for about 80% of the S protein after incubating with cells for 120 minutes. However, the Fab-form of P5A-1B8 nearly completely lost the ability of inducing the shedding of S1. P5A-1B9 and P5A-2G7 showed mild shedding ability. As a control and consistent with the expectation, S1 of the GSAS-containing mutant cannot be shed by either IgG or Fab (Fig. 3C ). The rest nAbs tested also exhibit similar properties (Fig. S10 ).

A summary of the above cryo-EM structure determinations enabled us to compare and classify the epitopes of these antibodies ( Fig. 4 and Fig. S11 ). In the final models, the The P5A-1B9 alone forms the group 2 among the eight neutralizing antibodies we have structurally characterized. The inter-molecular angle between P5A-1B9 and the RBD is 52 degrees anti-clockwise while the ACE2 degree is clockwise. Upon binding, P5A-1B9 approaches the RBD from a direction different from those of the first group antibodies. The epitope for P5A-1B9 has 6 residues overlapping with RBM. The heavy chain contributes 6 residues and the light chain contribute 2 residues. The shedding ability is 43.8%. The group 3 consists of antibodies P5A-2F11 and P5A-3C12, which use heavy chain genes from IGHV1 and IGHV2 family, respectively. The epitopes for antibodies in group 3 are mainly located in the remote loops and less overlapped with RBM, with only 6 or 4 overlapping residues for P5A-2F11 or P5A-3C12, respectively.

The heavy chain of P5A-2F11 plays the leading role while the light chain of P5A-3C12 plays the leading role. The shedding ability is higher than 54.5%.

In this work, we solved ten complex structures of the S protein with nAbs in full-length IgG form and/or in Fab form. Structural analysis revealed the bivalent binding mode of nAbs against SARS-CoV-2. Our biochemical and cell-based experimental results showed that the full-length IgG nAbs have greater binding ability, neutralization ability, and induce more S1 shedding than Fab. Similar results were also obtained in other study (27) . Moreover, there are more RBDs in ''up'' conformation in the structures of the S protein in complex with full-length IgG than that in complex with Fab. The difference should be attributed to the bivalent binding of IgG molecules that contain two Fab molecules. The full-length IgG nAbs bind to SARC-CoV-2 S proteins in bivalent mode with higher probability than the Fabs thus may induce stronger neutralization. Furthermore, the cooperation of the RBD conformational change induced by the bivalent binding would enhance the induced-conformational change of the S proteins on a virus surface. More importantly, the presence of Fc region in the antibody-virus complex can enhance the immunity response by the Fc receptors of T cells. Up to now, numerous complex structures of the S protein with nAb have been reported, most of which used nAb in Fab-form, especially those solved with X-ray crystallography. Our results suggest that the full-length IgG-form, which is more biologically relevant than Fab, should be used for the structural determination as much as possible to understand the structural and functional features of nAbs.

Among the ten nAbs reported in this research, the subgroup 1 and 2 of group 1 have a higher shedding ability (above 76 %), while the subgroup 3 of group 1, group 2 and group 3 show no or a weaker shedding ability (43.8% -57.2%). The group 1 has the largest overlap between the epitope and RBM, while the members in subgroup 3 have a rotation around the longitudinal axis of the Fab. The S1 shedding ability of the nAbs may be facilitated by the large overlap with RBM and require special angle to bind with RBD.

The SARS-CoV and SARS-CoV-2 cross-reactive antibodies that show neutralizing activity mainly target to RBD, interfere with ACE2 binding and stimulate S1 dissociation (28) , suggesting the ability to induce the shedding of S1 is correlated with the potency of the neutralizing nAbs. The shedding of S1 might be facilitated by the RBD in up conformation that is stabilized by the binding of nAb or receptor. It is not clear whether the shedding of all of three S1 subunits is required for the transition from the prefusion state to the postfusion state to catalyze the fusion of viral and cellular membrane or not. Our previous work indicates the receptor ACE2 exists as a dimer.

Each protomer of ACE2 dimer can be bound with one RBD from a S protein trimer and induces the bound RBD to the "up" conformation. It seems unlikely that one ACE2 dimer binds to a trimeric S protein simultaneously because of the steric clash. To induce more than one RBDs in a S protein to up conformation, multiple copies of ACE2 are 

A new coronavirus associated with human respiratory disease in China

A Novel Coronavirus from Patients with Pneumonia in China

A novel coronavirus associated with severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structural basis of receptor recognition by SARS-CoV-2

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Molecular architecture of the SARS-CoV-2 virus. bioRxiv

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Distinct conformational states of SARS-CoV-2 spike protein

Human neutralizing antibodies elicited by SARS-CoV-2 infection

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Structural basis of a shared antibody response to SARS-CoV-2

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Structure of a neutralizing antibody bound bivalently to human rhinovirus 2

Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization. bioRxiv

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. bioRxiv

Structural basis of a public antibody response to SARS-CoV-2. bioRxiv

An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain. bioRxiv

Structures of potent and convergent neutralizing antibodies bound to the SARS-CoV-2 spike unveil a unique epitope responsible for exceptional potency. bioRxiv

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells

We thank the cryo EM facility and the supercomputer center of Westlake University and the cryo-EM facility and the bio-computing platform at Tsinghua University 

Q. Zhou, L.Z., Z.Z., X.W., and H.W. conceived the project. R.Y., R.W., J.Y., Y.Z., N.L., B.J., J.W., Q. Zhang, P.C., B.Z., S.Z., L.T., X.Z., L.C. X.G. and J.Z. did the experiments. All authors contributed to data analysis. R.Y., R.W., J.Y., H.W., L.Z. and Q. Zhou wrote the manuscript.

The authors declare no competing interests.

Atomic coordinates and cryo EM density maps of the nAbs in complex with S protein have been deposited to the Protein Data Bank (http://www.rcsb.org) and the Electron Microscopy Data Bank (https://www.ebi.ac.uk/pdbe/emdb/), respectively. Please refer to